People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Scipher Medicine Corp | — | Biotechnology | Series C | $123.0M | $55.5M | 2021 |
| Mobilion Systems, Inc. | — | Biotechnology | Series C | $105.1M | $1.7B | 2020 |
| Arbor Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $22.0M | $592.2M | 2010 |
| Apicore Inc. | — | Pharmaceuticals | Series A | $16.7M | $22.3M | 2014 |
Todd Sone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Todd Sone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Jason Smith | 1 | 14 |
| Michael Rubin | 1 | 8 |
| Heiner Dreismann | 1 | 6 |
| James Gale | 1 | 5 |
| TIM ANDERSON | 1 | 3 |
| Miklos Kobor | 1 | 3 |
| Edward Schutter | 1 | 3 |
| Joseph Loscalzo | 1 | 3 |
| Jarrett Disbrow | 1 | 2 |
| Jeffrey Sachs | 1 | 2 |
| Alif Saleh | 1 | 2 |
| Ravishanker Kovi | 1 | 2 |
| ALBERT-LASZLO BARABASI | 1 | 2 |
| Peter Ruppert | 1 | 2 |
| Michael Albin | 1 | 2 |
| John Donofrio | 1 | 2 |
| ALAN AUBREY | 1 | 2 |
| Allen Chao | 1 | 2 |
| HEINER DREISSMAN | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.